Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Development Officer

Chief Financial Officer

Chief Operating Officer

Chief Scientific Officer

CEO, President and Director

Chief Medical Officer

See Remarks section

Chief Technology Officer

CEO and Director

President and CFO

Chief Legal Officer

President

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ixoberogene soroparvovec (ADVM-022), a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. The company is developing ADVM-062 (AAV.7m8-L-opsin), a novel gene therapy product candidate for the treatment of blue cone monochromacy via a single IVT injection. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular and rare diseases.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-07	Premium	bought	Premium	Premium	Premium	-
2024-02-07	Premium	bought	Premium	Premium	Premium	-
2023-09-15	Premium	sold	Premium	Premium	Premium	Chief Development Officer
2023-06-07	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2023-03-15	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2023-03-15	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-03-15	Premium	sold	Premium	Premium	Premium	CEO, President and Director
2022-09-19	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2022-09-19	Premium	sold	Premium	Premium	Premium	See Remarks section
2022-09-19	Premium	sold	Premium	Premium	Premium	Chief Development Officer
2022-09-19	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2022-09-19	Premium	sold	Premium	Premium	Premium	CEO, President and Director
2022-09-14	Premium	acquired	Premium	Premium	Premium	Chief Development Officer
2022-09-14	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2022-09-14	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2022-05-23	Premium	bought	Premium	Premium	Premium	Chief Development Officer
2022-05-17	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2022-05-17	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-05-16	Premium	bought	Premium	Premium	Premium	-
2022-05-13	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-04-20	Premium	bought	Premium	Premium	Premium	CEO, President and Director
2022-04-19	Premium	bought	Premium	Premium	Premium	See Remarks section
2021-12-09	Premium	bought	Premium	Premium	Premium	CEO, President and Director
2021-12-08	Premium	bought	Premium	Premium	Premium	CEO, President and Director
2021-12-08	Premium	bought	Premium	Premium	Premium	See Remarks section

ADVM - Adverum Biotechnologies Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ADVM